Skip to content
Aperlena
Free alerts
Log in

Spain - Pharmaceutical products - Supply of Alectinib (DOE), Atezolizumab (DOE), Cobimetinib (DOE), Dornase alfa (DOE), Pertuzumab (DOE), Polatuzumab vedotin (DOE), Subcutaneous Rituximab (DOE), Vemurafenib (DOE) and Vismodegib (DOE)

Original España - Productos farmacéuticos - Suministro de Alectinib (DOE), Atezolizumab (DOE), Cobimetinib (DOE), Dornasa alfa (DOE), Pertuzumab (DOE), Polatuzumab vedotina (DOE), Rituximab (DOE) subcutáneo, Vemurafenib (DOE) y Vismodegib (DOE)

Awarded Contract award

Key facts

Winner
ROCHE FARMA, S.A. UNIPERSONAL
Awarded value
€21,838,422
Estimated value
€31,665,712
Buyer
OSAKIDETZA - Servicio Vasco de Salud - Organización Central
Where
Spain País Vasco
Procedure
Negotiated procedure The buyer selects candidates, then negotiates the offers before choosing. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
33600000 Pharmaceutical products
Original language
Spanish
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 1 week ago
Notice number
618629-2026
Watch this tender

Bidding is closed. An award or a correction on this notice: an email when the register sees it. Log in

  1. Published
  2. Awarded pending

Summary

Machine-generated summary

Osakidetza - Basque Health Service - Central Organisation awarded a contract for the supply of nine medicines: Alectinib (DOE), Atezolizumab (DOE), Cobimetinib (DOE), Dornase alfa (DOE), Pertuzumab (DOE), Polatuzumab vedotin (DOE), subcutaneous Rituximab (DOE), Vemurafenib (DOE) and Vismodegib (DOE). The contract was won by ROCHE FARMA, S.A. UNIPERSONAL for EUR 21,838,422.10. The awarded price is 31% below the estimated value of EUR 31,665,712.05. The contract is divided into nine lots, one for each medicine.

Description

Suministro de Alectinib (DOE), Atezolizumab (DOE), Cobimetinib (DOE), Dornasa alfa (DOE), Pertuzumab (DOE), Polatuzumab vedotina (DOE), Rituximab (DOE) subcutáneo, Vemurafenib (DOE) y Vismodegib (DOE) L1_ALECTINIB (DOE); L2_ATEZOLIZUMAB (DOE); L3_COBIMETINIB (DOE); L4_DORNASA ALFA (DOE); L5_PERTUZUMAB (DOE); L6_POLATUZUMAB (DOE); L7_RITUXIMAB (DOE) SUBCUTÁNEO; L8_VEMURAFENIB (DOE); L9_VISMODEGIB (DOE)

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 1 week ago

View the official notice

More from this buyer

Full buyer profile

6 open tenders right now

Recent awards

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€10,020,608
9,792 open across Europe right now 216% above sector average
Buyer track record on Aperlena
556 notices tracked · 154 awarded
€1,978,170,865 in awarded contracts

Never miss a tender like this

756 new notices in Medical equipment & pharmaceuticals in Spain in the last 7 days. Get an email when new ones appear. Free.

Set up my alert
Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector